| Sean Robert Mcguinness, MD | |
|
317 W Pueblo St, Santa Barbara, CA 93105-4365 | |
| (805) 681-7500 | |
| Not Available |
| Full Name | Sean Robert Mcguinness |
|---|---|
| Gender | Male |
| Speciality | Hospitalist |
| Experience | 7 Years |
| Location | 317 W Pueblo St, Santa Barbara, California |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1497280515 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208M00000X | Hospitalist | A164325 (California) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Santa Barbara Cottage Hospital | Santa barbara, CA | Hospital |
| Goleta Valley Cottage Hospital | Santa barbara, CA | Hospital |
| Santa Ynez Valley Cottage Hospital | Solvang, CA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Sansum Clinic | 3678471976 | 276 |
News Archive
GenomeDx Biosciences today announced the publication of a positive validation study for the Decipher® Prostate Cancer Classifier, a genomic test for prostate cancer. The study, published in the Journal of Clinical Oncology, showed that patients with low genomic risk (as determined by Decipher) may be optimally managed with observation after radical prostatectomy (prostate surgery), while those with high genomic risk (as determined by Decipher) may be better managed earlier with adjuvant radiotherapy.
Community mental health clinics, where most specialty mental health treatment is delivered, have been relying more on independent contractors to treat patients, largely for budgetary reasons. Many of these clinics have simultaneously been moving towards the greater use of evidence-based psychosocial practices , broadly defined as talk therapies that are informed by rigorous research as well as clinician expertise and patient preferences.
Yissum Research Development Company Ltd., the technology transfer company of the Hebrew University of Jerusalem, and Hadasit Medical Research Services & Development Ltd., the technology transfer company of the Hadassah University Medical Center, today announced that they have licensed innovative regenerative membrane implant technology to RegeneCure, which will further develop and commercialize the technology for bone tissue engineering for applications in trauma, spine, and reconstructive cranial and facial orthopedics.
Biopsies were found to be the most costly tool prescribed in lung cancer diagnosis, according to research presented today at the 2014 Chicago Multidisciplinary Symposium in Thoracic Oncology.
› Verified 5 days ago
| Entity Name | Sansum Clinic |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1154354504 PECOS PAC ID: 3678471976 Enrollment ID: O20031223000607 |
News Archive
GenomeDx Biosciences today announced the publication of a positive validation study for the Decipher® Prostate Cancer Classifier, a genomic test for prostate cancer. The study, published in the Journal of Clinical Oncology, showed that patients with low genomic risk (as determined by Decipher) may be optimally managed with observation after radical prostatectomy (prostate surgery), while those with high genomic risk (as determined by Decipher) may be better managed earlier with adjuvant radiotherapy.
Community mental health clinics, where most specialty mental health treatment is delivered, have been relying more on independent contractors to treat patients, largely for budgetary reasons. Many of these clinics have simultaneously been moving towards the greater use of evidence-based psychosocial practices , broadly defined as talk therapies that are informed by rigorous research as well as clinician expertise and patient preferences.
Yissum Research Development Company Ltd., the technology transfer company of the Hebrew University of Jerusalem, and Hadasit Medical Research Services & Development Ltd., the technology transfer company of the Hadassah University Medical Center, today announced that they have licensed innovative regenerative membrane implant technology to RegeneCure, which will further develop and commercialize the technology for bone tissue engineering for applications in trauma, spine, and reconstructive cranial and facial orthopedics.
Biopsies were found to be the most costly tool prescribed in lung cancer diagnosis, according to research presented today at the 2014 Chicago Multidisciplinary Symposium in Thoracic Oncology.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Sean Robert Mcguinness, MD Po Box 62106, Santa Barbara, CA 93160-2106 Ph: () - | Sean Robert Mcguinness, MD 317 W Pueblo St, Santa Barbara, CA 93105-4365 Ph: (805) 681-7500 |
News Archive
GenomeDx Biosciences today announced the publication of a positive validation study for the Decipher® Prostate Cancer Classifier, a genomic test for prostate cancer. The study, published in the Journal of Clinical Oncology, showed that patients with low genomic risk (as determined by Decipher) may be optimally managed with observation after radical prostatectomy (prostate surgery), while those with high genomic risk (as determined by Decipher) may be better managed earlier with adjuvant radiotherapy.
Community mental health clinics, where most specialty mental health treatment is delivered, have been relying more on independent contractors to treat patients, largely for budgetary reasons. Many of these clinics have simultaneously been moving towards the greater use of evidence-based psychosocial practices , broadly defined as talk therapies that are informed by rigorous research as well as clinician expertise and patient preferences.
Yissum Research Development Company Ltd., the technology transfer company of the Hebrew University of Jerusalem, and Hadasit Medical Research Services & Development Ltd., the technology transfer company of the Hadassah University Medical Center, today announced that they have licensed innovative regenerative membrane implant technology to RegeneCure, which will further develop and commercialize the technology for bone tissue engineering for applications in trauma, spine, and reconstructive cranial and facial orthopedics.
Biopsies were found to be the most costly tool prescribed in lung cancer diagnosis, according to research presented today at the 2014 Chicago Multidisciplinary Symposium in Thoracic Oncology.
› Verified 5 days ago
Jeffrey B Yim, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 317 W Pueblo St, Santa Barbara, CA 93105 Phone: 805-681-1761 Fax: 805-681-1768 | |
Anh Lam, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 317 W Pueblo St, Santa Barbara, CA 93105 Phone: 805-898-3077 | |
Dung-hoa T Nguyen, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 317 W Pueblo St, Santa Barbara, CA 93105 Phone: 805-681-1761 Fax: 805-681-1768 | |
Jeremy L Lash, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 317 W Pueblo St, Santa Barbara, CA 93105 Phone: 805-898-3077 Fax: 805-898-3058 | |
Philip Wan, D.O. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: Sbch, Medical Education, 400 W Pueblo Street, Santa Barbara, CA 93015 Phone: 805-569-7315 Fax: 805-569-8358 | |
Ms. Erin K Hammett, DO. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 317 W Pueblo St, Santa Barbara, CA 93105 Phone: 805-898-3077 Fax: 805-898-3058 |